default author photo

Daniel Gomez

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

SCHOLARLY PAPERS

4

DOWNLOADS

345

TOTAL CITATIONS

4

Scholarly Papers (4)

1.

Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression - Randomised Study of Stereotactic Body Radiotherapy in Patients with Oligoprogressive Cancers of the Breast and Lung

Number of pages: 33 Posted: 15 Jun 2023
Princess Margaret Hospital, University of Washington, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, University of Washington, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Pathology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology and Independent
Downloads 166 (451,954)
Citation 3

Abstract:

Loading...

oligoprogression, oligoprogressive, stereotactic body radiotherapy, SBRT, stereotactic ablative radiotherapy, SABR, non-small-cell lung cancer, NSCLC, breast cancer, ctDNA, cfDNA, circulating tumor DNA, liquid biopsy

2.

Characterization of Central Nervous System Clinico-Genomic Outcomes In  ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

Number of pages: 32 Posted: 28 Dec 2022
Yeshiva University - Albert Einstein College of Medicine, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center
Downloads 86 (765,566)

Abstract:

Loading...

ALK, Brain Metastases, Non-Small Cell Lung Cancer, Central Nervous System, CNS Radiation

3.

ROE (Radiotherapy Outcomes Estimator): An Open-Source Tool for Optimizing Radiotherapy Prescriptions

Number of pages: 23 Posted: 13 Jul 2023
Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Columbia University, Memorial Sloan Kettering Cancer Center, Tennessee Oncology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center
Downloads 58 (980,173)

Abstract:

Loading...

Radiotherapy outcome modelling, prescription determination, tumor control probability, normal tissue complication probability, radiotherapy analysis software

4.

Optimal Systemic Treatment and Real-World Clinical Application of Ctdna in Patients with Metastatic Her2-Mutant Lung Cancer

Number of pages: 15 Posted: 15 May 2024
Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Exact Sciences Corporation, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center
Downloads 35 (1,249,711)
Citation 1

Abstract:

Loading...

immunotherapy, Targeted Therapy, HER2 mutation, ctDNA, NSCLC